Neurobene

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neurobene

Quick Facts: Neurobene (Cyanocobalamin)

Property Description
Active ingredient Cyanocobalamin (Vitamin B12)
Form Oral tablets, Solution for injection (Ampoules)
Pharmacological class Water-soluble vitamin, Hematopoietic agent
Common use Prevention and treatment of deficiency states
Origin Synthetic analog of a natural nutrient

Classification and Core Composition

Neurobene is a pharmaceutical preparation containing the active ingredient Cyanocobalamin, which is classified as an essential nutrient and a water-soluble vitamin (Vitamin B12). Pharmacologically, this compound is categorized as a Hematopoietic agent, meaning it supports the fundamental process of forming mature blood cells. Cyanocobalamin is the most stable, synthetic analog of B12, belonging chemically to the Corrinoid family, distinguished by its central cobalt atom. Cyanocobalamin must be converted by the body into metabolically active forms to support cellular function. This synthetic form is widely used in replacement therapy and may be offered as a monocomponent preparation or a combination product with other B-vitamins like B1 and B6.


Forms, Origin, and Therapeutic Role

Neurobene is commonly available in two primary dosage forms: the oral tablet and a sterile solution for injection contained in ampoules. The existence of various preparations, including both oral and parenteral routes of administration, ensures that treatment can be tailored to patient needs. For instance, injectable solutions are often necessary for individuals with severe B12 malabsorption syndromes, ensuring the essential substance bypasses a compromised digestive system. The core therapeutic purpose of the medicine is to address and prevent the systemic decline associated with deficiency states. This vital compound is integral for both red blood cell formation (erythropoiesis) and maintaining the structural integrity of the myelin sheath, supporting proper nerve tissue metabolism.

Regulatory References

  1. WHO Classification of Haematolymphoid Tumours

What side effects are possible with Neurobene?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse effects and formal safety characteristics of Neurobene (Cyanocobalamin), as reported in governmental regulatory documents. This information is purely descriptive and is not intended as medical advice or instruction.


Documented Adverse Reactions

The most common adverse reactions listed in regulatory safety information primarily affect the skin and immune system. These effects are categorized by the affected body system, known as System-Organ Classes (SOCs):

System-Organ Class Officially Documented Effects
Skin and Subcutaneous Tissue Rash, Pruritus (itching), Urticaria (hives)
Immune System Allergic reactions, Hypersensitivity
Gastrointestinal Diarrhea
Nervous System Headache

Frequency and Serious Reactions

Adverse reactions are classified according to how often they are expected to occur:

  • Rare Effects: Serious hypersensitivity reactions, including anaphylaxis, are classified as rare, meaning they affect no more than 1 in 1,000 users, based on clinical trial data. Anaphylaxis is the most severe immune system reaction documented.
  • Frequency Not Known: The official frequency of other listed effects, such as rash, diarrhea, or headache, cannot be estimated from the available data and are classified as Not Known.

Safety Restrictions (Contraindications)

Official regulatory labeling outlines specific situations where Neurobene must not be used:

  • Known Hypersensitivity: The medicine is contraindicated in individuals with a known allergy to Cyanocobalamin or any excipients in the formulation.
  • Hereditary Optic Atrophy: Use is contraindicated in patients with Leber's disease or tobacco amblyopia, due to the risk of worsening optic nerve damage.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Neurobene (Cyanocobalamin) consistently notes that acute overdosage is virtually unknown. As a water-soluble vitamin, excess Cyanocobalamin is generally non-toxic and is rapidly excreted in the urine by the body's natural processes. This low toxicity means that specific life-threatening overdose syndromes are not typically documented in official labeling.

Documented Manifestations and Actions

The most important actions following any suspected excessive intake are regulatory mandates for safety and procedure:

  • Mandatory action: Seek immediate medical attention for any suspected overdose. Emergency services should be contacted immediately if symptoms of severe hypersensitivity, such as difficulty breathing or swelling (anaphylactic shock), are observed following administration.
  • Overdose Management: Treatment is primarily symptomatic and supportive. This includes the cessation of the medication and clinical observation.
  • Antidote Status: Regulatory information states that no specific antidote is known for Cyanocobalamin overdose.

Immediate medical help is required upon any suspected overdose, regardless of expected severity, to address potential adverse events and procedural monitoring requirements.

Therapeutic Uses of Neurobene

Quick Facts

  • Used in the dietary management of Vitamin B deficiencies (B1, B6, B12).
  • Employed as a therapeutic option to support healthy nervous system function.
  • Intended to assist with conditions associated with specific nutrient depletion.

Neurobene is a formulation that may assist in the dietary management of deficiencies in B vitamins, specifically Thiamine (B1), Pyridoxine (B6), and Cyanocobalamin (B12). These B-complex vitamins are essential for various metabolic processes and play a role in maintaining the function of the nervous system and supporting red blood cell formation.

This medication is primarily indicated for use as a supplement in individuals who have confirmed low levels of these nutrients or who are at risk of developing such deficiencies. Neurobene is utilized in therapeutic strategies intended to support overall nervous system health and may be an available treatment option in the management of certain nerve-related symptoms associated with B vitamin depletion.

Its application is aligned with established practices for addressing nutrient deficits. A qualified healthcare professional determines the appropriate use of this medication based on an individual’s specific clinical needs and status.

Eligibility and Restrictions for Use

Who Can and Cannot Use Neurobene?

This section outlines the official population eligibility and non-eligibility for Neurobene (Cyanocobalamin) as defined in government regulatory labeling.

Eligibility Scope

Classification Population or Condition Status
Contraindicated Hypersensitivity to Cyanocobalamin or Cobalt Prohibited
Contraindicated Early Leber's Disease (hereditary optic nerve atrophy) Prohibited
Conditional Use Renal Impairment (Kidney Disease) Caution Required
Conditional Use Premature Neonates Caution Required
Conditional Use Suspected Megaloblastic Anemia Restricted
Age Groups Adults and the Elderly Generally Eligible
Age Groups Children and Adolescents Generally Eligible

Official Eligibility Statements

  • The medicine is contraindicated in patients with a history of allergy to the active substance or its metallic component, cobalt.
  • Use is prohibited in patients diagnosed with early Leber’s Disease, as this condition is an absolute contraindication in regulatory documents.
  • Use requires caution in patients with impaired kidney function, particularly with parenteral (injectable) administration, due to the risk of aluminum accumulation.
  • Premature neonates are identified as a population requiring caution due to specific excipient risks in certain injectable formulations.
  • In pregnancy, the medicine may be used, though it is prohibited for treating megaloblastic anemia if the cause is solely folic acid deficiency, as it can mask the correct diagnosis. The substance is distributed into breast milk and is generally considered acceptable during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interactions based on the active components (B-vitamins) of Neurobene.

Interacting Medicines and Classes

The most significant interactions involve medicines where the B-vitamins, particularly Pyridoxine (Vitamin B6), may alter the medicine's therapeutic effect or metabolism.

Category Specific Medicines/Examples Interaction Constraint
Anti-Parkinsonian Agents Levodopa (without a DOPA decarboxylase inhibitor) Contraindicated/Not Recommended: Pyridoxine accelerates Levodopa metabolism, reducing efficacy.
Anticonvulsants Phenytoin, Phenobarbital Caution: These medicines may increase the metabolic breakdown of Pyridoxine, potentially lowering B6 levels.
Drugs Affecting Absorption Metformin, H2-receptor antagonists, Proton Pump Inhibitors, Colchicine Caution: May interfere with the absorption or utilization of Vitamin B12 and Folic Acid, reducing their effectiveness.
Tuberculosis Medicines Isoniazid, Hydralazine Caution: These medicines may increase the body's requirement for Pyridoxine or interfere with its action.

Profile Summary

The interaction profile of Neurobene is structured around the potential for Pyridoxine to diminish the therapeutic effect of Levodopa, an interaction classified as clinically significant and generally contraindicated. Furthermore, various other medicines, including certain antibiotics, anti-epileptics, and those used for stomach acid reduction, may impact the body's absorption or metabolism of the B-vitamins present in the product. Patients are advised that these documented interactions necessitate specific clinical adjustments or close monitoring as defined in the official product labeling for the safety and effectiveness of all medicines being used concomitantly.

Mechanism of Action

The active ingredient in Neurobene, Cyanocobalamin (Vitamin B12), functions exclusively as an essential metabolic cofactor for two key enzyme systems, influencing both cell division and nerve structure.

B12 Cofactor in Cellular DNA Synthesis

This mechanism centers on the activation of the cytoplasmic enzyme Methionine Synthase (MTR) by its active form, Methylcobalamin. By enabling the MTR reaction, the molecule supports the critical biochemical recycling of folate, which is directly necessary for synthesizing the DNA building blocks (purines and pyrimidines) required for healthy cell division and maturation in all rapidly dividing cells, including those in the hematopoietic system.

Metabolic Role in Myelin Maintenance and Nerve Integrity

The second mechanism involves the coenzyme form Adenosylcobalamin, which is required by the mitochondrial enzyme L-Methylmalonyl-CoA Mutase (MMUT). This enzyme regulates lipid pathways by converting toxic precursors into an energy-cycle intermediate. This action is essential for preventing the accumulation of substances that can destabilize the myelin sheath surrounding nerve axons, thereby supporting the metabolic processes necessary for neurological integrity.

Constraints on Mechanism Execution

The execution of the mechanism is constrained by the required delivery of the molecule to its intracellular targets. The oral delivery mechanism is constrained by the need to bind to Intrinsic Factor for absorption. The molecular action is functionally limited if the Intrinsic Factor transport mechanism is absent, preventing the molecule from accessing the systemic circulation.

Dosage and Administration Information

Administration Overview

Neurobene is typically administered as an oral therapy. The method of intake is designed to ensure consistent absorption of the active components within the gastrointestinal tract. To maintain stable concentrations of the substance in the bloodstream, it is generally recommended to establish a regular routine for administration.

Oral Consumption

The tablets or capsules should be swallowed whole with a sufficient amount of water. Crushing, chewing, or breaking the medication can alter the intended release profile, which may affect how the body processes the ingredients. Consistency regarding food intake is also a factor; the medication can often be taken regardless of meal timing, provided the approach remains the same each day to avoid fluctuations in absorption.

Routine and Consistency

Establishing a specific time of day for administration helps in maintaining the therapeutic window. If a routine is interrupted, it is standard practice to resume the regular schedule at the next scheduled interval rather than attempting to compensate for the missed application.

Storage and Handling

Proper handling of the medication involves keeping it in its original packaging until the point of use to protect it from environmental factors such as light and moisture. Maintaining the integrity of the storage environment ensures that the chemical properties of the medication remain stable throughout its shelf life.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research Focus on Possible Action

Research has explored a possible mechanism involving activation of a specific class of receptors in the central nervous system. Research has also investigated this area regarding its potential role in pain signaling pathways. Further studies have explored the drug's effect on measured markers of inflammation.


Clinical Efficacy Studies

Studies examined changes in chronic pain symptoms following administration of the drug. These studies focused on participants with chronic, severe pain conditions who were administered the drug in various controlled settings. Research data collected included participant-reported scores on validated pain scales and quality-of-life assessments.

Studies have explored the comparative effects of the drug against other treatments used for managing severe pain. This research evaluated differences in measured outcomes, such as changes in pain intensity over time, between the study groups.


Combination Therapy

Studies assessed whether combining the drug with standard therapy affected measured patient outcomes. This research typically involved a control group receiving only standard therapy versus an intervention group receiving both the drug and standard therapy. The research focused on outcomes such as reduction in symptom severity and the need for rescue medication.


Tolerability and Pharmacokinetics

Long-term studies evaluated the occurrence and nature of adverse events in adult participants over an extended period.

Research has examined the pharmacokinetics of the drug in participants with varying degrees of kidney function. These studies help determine how the drug behaves in the body's systems, particularly where clearance is concerned.

Frequently Asked Questions (FAQ)

Common questions about Neurobene (FAQ)


Q: How long does it usually take to feel the effects of Neurobene?

Evidence from clinical data indicates that for conditions like megaloblastic anemia, a measurable response in the bone marrow is described as occurring within eight hours, and an increase in red blood cell precursors may be observable in two to five days. Resolution of related symptoms, such as some psychiatric symptoms, has been reported within 24 hours of starting treatment.


Q: Do you have to take Neurobene forever, or can you stop after a time?

For deficiency caused by conditions like pernicious anemia, treatment is often described in regulatory documents as required lifelong. For other types of deficiency that are not related to permanent malabsorption, the duration of use is typically established based on the individual's clinical needs and condition.


Q: Are there any common foods or drinks that should be avoided while using Neurobene?

Official product information for oral forms generally suggests taking the medication on an empty stomach (such as thirty minutes before or two hours after a meal) to optimize absorption. Beyond this constraint on absorption timing, specific foods or drinks are not formally prohibited in the official product information.


Q: Can Neurobene affect my sleep schedule?

Official safety documentation lists adverse reactions by the body system affected. Common sleep problems like insomnia or excessive sleepiness are not explicitly listed as documented adverse reactions.


Q: Is it normal to feel a change in energy levels when starting Neurobene?

The medicine’s core purpose is to address and prevent the systemic decline associated with deficiency states. Addressing the deficiency may result in changes to energy levels, which is consistent with the drug's role in supporting red blood cell formation and nerve tissue metabolism.


Q: Are there any known interactions between Neurobene and herbal supplements?

Official guidance states that patients are generally advised to inform their healthcare professional about all products being taken. This includes prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products.


Q: What is the duration of action for a single dose of Neurobene?

Pharmacokinetic data indicate that following an intramuscular (IM) or deep subcutaneous (SC) injection, the Time to Peak serum concentration—when the medicine reaches its highest level in the blood—is documented to occur within 30 minutes to 2 hours.


Q: Does taking Neurobene with food change how it works?

Taking oral tablets with food may affect the speed and overall amount of the compound absorbed by the body. To ensure optimal absorption, official guidance may suggest taking the tablet on an empty stomach.


Q: Can Neurobene be crushed or split?

Official administration constraints state that specific formulations, such as extended-release tablets, are to be swallowed whole and are generally not intended to be crushed or chewed. This constraint ensures the medicine releases into the body over the intended period.


Q: Is Neurobene a type of vitamin or a prescription drug?

The active ingredient, Cyanocobalamin, is classified as an essential nutrient and a water-soluble vitamin (Vitamin B12) by governmental health bodies. It is available in various preparations, some of which are sold over the counter, while others require a prescription, particularly the high-dose or injectable forms used for severe conditions like pernicious anemia.


Q: Is Neurobene used in other countries for different purposes?

While the compound's core therapeutic purpose remains B12 deficiency globally, some international documents note that other chemically related forms of the compound may be the preferred agent in parts of Europe. Additionally, combination products may be available in different countries for a wider range of uses.


Q: Is Neurobene considered a habit-forming drug?

According to official regulatory classifications, the active ingredient is a vitamin and an essential nutrient. It is not listed or classified as a narcotic, controlled substance, or habit-forming drug in official regulatory documentation.


Q: Does Neurobene have any known warnings for people with kidney problems?

Official labeling advises that use requires caution in patients with impaired kidney function. This warning is due to the potential for more serious side effects, including the risk of aluminum accumulation that may be present in certain injectable forms.


Q: Why is Neurobene sometimes described as a 'neuro' drug?

The compound is described in regulatory information as vital for maintaining the structural integrity of the myelin sheath—the protective covering around nerves. The drug supports metabolic processes necessary for neurological function, which is the basis for its 'neuro' descriptor.


Q: Do I need to store Neurobene in the refrigerator or at room temperature?

The medication is generally instructed to be stored at room temperature, adhering to the maximum temperature threshold listed on the product label (e.g., below 25 C or 77 F). It must be kept in its original outer carton to protect it from light and maintain stability.

How should Neurobene be stored and disposed of?

Official Storage and Disposal Profile

The storage and disposal requirements for Neurobene are strictly based on government regulatory documents (e.g., SmPC, Prescribing Information).

Storage Conditions:

The medication must be stored according to the specific maximum temperature threshold listed on the product label (e.g., below 25 C). To ensure stability and protect the contents from light, the medicine must be kept in its original outer carton and container.

Classification Requirement
Temperature Adhere to label maximum
Light Protection Store in original container
Stability Valid until printed expiry date

Disposal Rules:

The full shelf-life is valid only if all official storage conditions are maintained. Any unused, expired, or waste medicinal product must be disposed of according to local requirements and established governmental waste management protocols. No specific hazardous-waste instructions are generally documented beyond standard local disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neurobene found in:

A-Z Index: